Adoptive Cell Immunotherapy in Relapse/Refractory Epstein–Barr Virus-Driven Post-Transplant Lymphoproliferative Disorders

Post-transplant lymphoproliferative disorders (PTLD) represent a life-threatening complication following solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in patients with relapsed or refractory (R/R) disease, where therapeutic options...

Descripció completa

Dades bibliogràfiques

Autors principals:	Martina Canichella, Paolo de Fabritiis
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-06-01
Col·lecció:	Antibodies
Matèries:	PTLD—post-transplant lymphoproliferative disorders RIS—reduction in immunosuppression EBV—Epstein–Barr virus allo-HSCT—allogeneic stem cell transplantation
Accés en línia:	https://www.mdpi.com/2073-4468/14/2/47
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!